Rogier Caluwé

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial

An S. De Vriese, Rogier Caluwé, Hans Van Der Meersch et al. · Journal of the American Society of Nephrology · 2021 · 172 citations · Full text

Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study

An S. De Vriese, Rogier Caluwé, Lotte Pyfferoen et al. · Journal of the American Society of Nephrology · 2019 · 168 citations · Full text

Hypertension, Heart Failure, Vitamin K Status +22

Dose-Finding Study of Rivaroxaban in Hemodialysis Patients

An S. De Vriese, Rogier Caluwé, Els Bailleul et al. · American Journal of Kidney Diseases · 2015 · 142 citations

Therapeutic Drug Monitoring, Hemodialysis, Hemodialysis Patients +7

Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study

Rogier Caluwé, Stefaan J. Vandecasteele, Bruno Van Vlem et al. · Nephrology Dialysis Transplantation · 2013 · 125 citations · Full text

Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study

Jens Van Praet, Marijke Reynders, Dirk De Bacquer et al. · Journal of the American Society of Nephrology · 2021 · 94 citations · Full text